{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:12:11Z","timestamp":1769170331520,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12325-021-01708-8","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T08:03:05Z","timestamp":1620201785000},"page":"3154-3165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis"],"prefix":"10.1007","volume":"38","clinical-trial-number":[{"clinical-trial-number":"nct02614183","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02614196","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02614261","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Patricia","family":"Pozo-Rosich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-9232","authenticated-orcid":false,"given":"Karen H.","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd J.","family":"Schwedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallikarjuna","family":"Rettiganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Pearlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"1708_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jns.2016.11.071","volume":"372","author":"YW Woldeamanuel","year":"2017","unstructured":"Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307\u201315.","journal-title":"J Neurol Sci"},{"key":"1708_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343\u20139.","journal-title":"Neurology"},{"key":"1708_CR3","doi-asserted-by":"publisher","unstructured":"Lipton RB, Araujo AB, Nicholson RA, et al. Patterns of diagnosis, consultation, and treatment of migraine in the US: results of the OVERCOME study. In: 61st Annual Scientific Meeting American Headache Society\u00ae 2019 Headache. 2019;59:2\u20133. https:\/\/doi.org\/10.1111\/head.13549.","DOI":"10.1111\/head.13549"},{"issue":"S1","key":"1708_CR4","first-page":"127","volume":"60","author":"S Ashina","year":"2020","unstructured":"Ashina S, Nicholson RA, Buse DC, et al. Identifying barriers to care-seeking, diagnosis, and preventive medication among those with migraine: results of the OVERCOME study [abstract]. Headache. 2020;60(S1):127\u20138.","journal-title":"Headache"},{"issue":"S1","key":"1708_CR5","first-page":"126","volume":"60","author":"RA Nicholson","year":"2020","unstructured":"Nicholson RA, Lipton RB, Reed ML, et al. Characteristics of individuals with migraine who are eligible for novel CGRP monoclonal antibodies: results of the OVERCOME study [abstract]. Headache. 2020;60(S1):126\u20137.","journal-title":"Headache"},{"key":"1708_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.18553\/jmcp.2014.20.1.22","volume":"20","author":"Z Hepp","year":"2014","unstructured":"Hepp Z, Bloudek LM, Varon SF. Systematic review of migraine prophylaxis adherence and persistence. J Manag Care Pharm. 2014;20:22\u201333.","journal-title":"J Manag Care Pharm"},{"key":"1708_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2147\/NDT.S3497","volume":"4","author":"D D\u2019Amico","year":"2008","unstructured":"D\u2019Amico D, Tepper SJ. Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat. 2008;4:1155\u201367.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1708_CR8","unstructured":"EMGALITY (Prescribing Information). Indianapolis, IN: Eli Lilly and Company, 2019. https:\/\/pi.lilly.com\/us\/emgality-uspi.pdf."},{"key":"1708_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2018.1212","volume":"75","author":"VL Stauffer","year":"2018","unstructured":"Stauffer VL, Dodick DW, Zhang Q, Carter JN, Ailani J, Conley RR. Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial. JAMA Neurol. 2018;75:1080\u20138.","journal-title":"JAMA Neurol"},{"key":"1708_CR10","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1177\/0333102418779543","volume":"38","author":"V Skljarevski","year":"2018","unstructured":"Skljarevski V, Matharu M, Millen BA, Ossipov MH, Kim B-K, Yang JY. Efficacy and safety of galcanezumab for the prevention of episodic migraine: results of the EVOLVE-2 phase 3 randomized controlled clinical trial. Cephalalgia. 2018;38:1442\u201354.","journal-title":"Cephalalgia"},{"key":"1708_CR11","doi-asserted-by":"publisher","first-page":"e2211","DOI":"10.1212\/WNL.0000000000006640","volume":"19","author":"HC Detke","year":"2018","unstructured":"Detke HC, Goadsby PJ, Wang S, Friedman DI, Selzler KJ, Aurora SK. Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study. Neurology. 2018;19:e2211\u201321.","journal-title":"Neurology"},{"key":"1708_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/head.13691","volume":"60","author":"HC Detke","year":"2020","unstructured":"Detke HC, Millen BA, Zhang Q, et al. Rapid onset of effect of galcanezumab for the prevention of episodic migraine: analysis of the EVOLVE studies. Headache. 2020;60:348\u201359.","journal-title":"Headache"},{"key":"1708_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10194-018-0951-2","volume":"19","author":"S F\u00f6rderreuther","year":"2018","unstructured":"F\u00f6rderreuther S, Zhang Q, Stauffer VL, Aurora SK, Lainez MJA. Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo controlled EVOLVE-1, EVOLVE-2, and REGAIN studies. J Headache Pain. 2018;19:121.","journal-title":"J Headache Pain"},{"key":"1708_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629\u2013808.","journal-title":"Cephalalgia"},{"key":"1708_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12911-016-0359-3","volume":"16","author":"S O\u2019Connor","year":"2016","unstructured":"O\u2019Connor S, Hanlon P, O\u2019Donnell CA, Garcia S, Glanville J, Mair FS. Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualititave studies. BMC Med Inform Decis Mak. 2016;16:120.","journal-title":"BMC Med Inform Decis Mak"},{"key":"1708_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1037\/dev0000081","volume":"52","author":"BM Reynolds","year":"2016","unstructured":"Reynolds BM, Robles TF, Repetti RL. Measurement reactivity and fatigue effects in daily diary research with families. Dev Psychol. 2016;52:442\u201356.","journal-title":"Dev Psychol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01708-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01708-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01708-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:37:03Z","timestamp":1628613423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01708-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01708-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}